Gary Kupfer MD
Professor of Pediatrics (Hematology / Oncology) and of Pathology; Clinical Program Leader, Pediatric Hematology & Oncology Program, Smilow Cancer Hospital; Section Chief, Pediatric Hematology/Oncology; Clinical Research Program Leader, Pediatric Hematology & Oncology Program, Yale Cancer Center
Pediatric oncology; genetic markers for diagnosis, prognosis, staging and tracking disease in patients.
gary_kupfer faculty-clinics false true false Clinical Trials
Conditions Study Title Sarcoma Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma Chordoma, Desmoid Tumor, Adult Rhabdomyosarcoma, Childhood Desmoplastic Small Round Cell Tumor, Metastatic Childhood Soft Tissue Sarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma, and Soft Tissue A COG Soft Tissue Sarcoma Diagnosis, Biology and Banking Protocol (COG 9902) Central Nervous System Tumor and Brain and Nervous System A Study Evaluating Limited Target Volume Boost Irradiation and Reduced Dose Craniospinal Radiotherapy (18.00 Gy) and Chemotherapy in Children with Newly Diagnosed Standard Risk Medulloblastoma: A Phase III Double Randomized Trial (COG ACNS0331) Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia, and Lymphoid Leukemia Treatment of Patients with Newly Diagnosed Standard Risk B-Precursor Acute Lymphoblastic Leukemia (AALL0932) (CIRB) Childhood Infratentorial Ependymoma, Childhood Supratentorial Ependymoma, Newly Diagnosed Childhood Ependymoma, and Brain and Nervous System Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients with Newly Diagnosed Ependymoma Ages 1 to 21 Years (COG ACNS0831) (CIRB)